iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board

MARTINSRIED, Germany and MUNICH, Oct. 9, 2019 /PRNewswire/ — iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, today announced significant changes to the company’s executive management team. Apollon…

About the Author

has written 41555 stories on this site.

Copyright © 2010 Business and Corporate News.